Aripiprazole is effective in hyperprolactinemia secondary to use of Fluphenazine

Authors

  • Smit Shah MS-4, Rutgers Robert Wood Johnson Medical School, New Jersey
  • Pooja Shah Resident Physician, Delaware Psychiatric Center, Delaware
  • Salman Salaria Resident Physician, Delaware Psychiatric Center, Delaware & Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD
  • Osman Salaria Resident Physician Mount Sinai Medical Center of Florida, Florida

DOI:

https://doi.org/10.3329/seajph.v7i2.38855

Keywords:

Hyperprolactinemia, Fluphenazine, Aripiprazole, Hallucinations, Prolactin

Abstract

Aripiprazole is drug that acts as a partial agonist at D2 and 5-HT1A receptors and antagonist at 5-HT2A receptor. It modulates the neurotransmission over activity on the dopaminergic mesolimbic pathway which is responsible for positive symptoms of Schizophrenia. Dopamine antagonism is the mechanism of action of first generation antipsychotics. In this paper we discuss an interesting case in which Aripiprazole was effective in decreasing Prolactin levels which was elevated secondary to previous Fluphenazine use.

South East Asia Journal of Public Health Vol.7(2) 2017: 40-42

Downloads

Download data is not yet available.
Abstract
653
PDF
625

Downloads

Published

2018-11-28

How to Cite

Shah, S., Shah, P., Salaria, S., & Salaria, O. (2018). Aripiprazole is effective in hyperprolactinemia secondary to use of Fluphenazine. South East Asia Journal of Public Health, 7(2), 40–42. https://doi.org/10.3329/seajph.v7i2.38855

Issue

Section

Case Study